Physician profile
Alter Peerless
NPI 1780674986
$631.33
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $66.85 · 2022: $190 · 2023: $180 · 2024: $14.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $142.13 | 2022-2023 | |
| Alk-Abello, INC | $110.33 | 2019-2024 | Timothy, Standardized, Standardized Mite D. Farinae, Alternaria Tenuis |
| Optinose US, INC. | $95.23 | 2019-2023 | |
| Stryker Corporation | $58.29 | 2019-2022 | |
| Intersect Ent, INC. | $54.36 | 2019 | |
| Aerin Medical INC. | $39.31 | 2020 | |
| Phadia US INC. | $32.92 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $21.02 | 2023 | Dupixent |
| Baxter Healthcare | $18.32 | 2019 | |
| Kaleo, INC. | $16.88 | 2022 | |
| Hikma Pharmaceuticals USA | $15.00 | 2023 | Ryaltris |
| Zyla Life Sciences, INC. | $14.45 | 2020 | |
| Merck Sharp & Dohme LLC | $13.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alter Peerless listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.